Serum samples from patients with mycobacterial infections cross-react with HIV structural proteins Gp41, p55 and p18

Leprosy Review

Volumn 78, Issue 2, 2007, Pages 137-147

  Hussain, Tahziba ^a   Sinha, Shikha ^a   Katoch, Kiran ^a   Yadav, V S ^a   Kulshreshtha, K K ^a   Singh, Itu ^a   Sengupta, U ^a   Katoch, V M ^a  

^a NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GLYCOPROTEIN GP 41; PROTEIN P18; PROTEIN P52; PROTEIN P55;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LEISHMANIASIS; LEPROSY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NUCLEOTIDE SEQUENCE; SCHOOL CHILD; SEQUENCE ANALYSIS; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BLOTTING, WESTERN; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; LEPROSY; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE;

EID: 34548855954     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hussain T, Kulshreshtha K, Ghei SK, Natarajan M, Katoch K, Sengupta U. HIV seroprevalence in leprosy patients. Int J Lep, 2000; 68: 67-69.
2. Hussain T, Sinha S, Kulshreshtha KK, Katoch K, Yadav VS, Sengupta U, Katoch VM. Seroprevalence of HIV infection among leprosy patients in Agra, India: Trends and perspective. Int J Lep, 2005; 73(2): 93-99.
3. Shivraj L, Patil SA, Girdhar A, Sengupta U, Desikan KV, Srinivasan H. Antibodies to HIV-1 in sera from patients with mycobacterial infections. Int J Lep, 1988; 56: 546-551.
4. Ridley DS, Jopling WH. Classification of leprosy according to immunity: a five group system. Int J Lep, 1966; 34: 255-267.
5. Nunn PP, McAdam RPWJ. Mycobacterial infections and AIDS. Br Med Bull, 1988; 44: 801-803.
6. Orege PA, Fine PEM, Lucas SB, Obura M, Okelo C, Okuku P, Were M. A case control study on human immunodeficiency virus-1 (HIV-1) infection as a risk factor for tuberculosis and leprosy in Western Kenya. Tuber Lung Dis, 1993; 74(6): 377-381.
7. Pönnighaus JM, Mwanjasi LJ, Fine PEM, Shaw MA, Turner AC, Oxborrow SN, Lucas SB, Jenkins PA, Sterne JA, Bliss L. Is HIV infection a risk factor for leprosy? Int J Lepr, 1991; 59: 221-228.
8. Ustianowski AP, Lawn SD, Lockwood DNJ. Interactions between HIV infection and leprosy: a paradox. Lancet, 2006; 6: 1-11.
9. Miller RA. Leprosy and AIDS: a review of the literature and speculations on the impact of CD4 + lymphocyte depletion on immunity to Mycobacterium leprae. Int J Lepr, 1991; 59: 639-644.
10. Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS, 2002; 16: 1119-1129.
11. Mylonakis E, Paliou M, Greenbough TC, Flaningan TP, Letvin NL, Rich JD. Report of a false-positive HIV test result and the potential use of additional tests in establishing HIV serostatus. Arch Intern Med, 2000; 160: 2386-2388.
12. Proffitt MR, Yen-Lieberman B. Laboratory diagnosis of human immunodeficiency virus infection. Inf Dis Clin North AM, 1993; 7: 203-219.
13. Lundberg GD. Serological diagnosis of Human Immunodeficiency Virus infection by Western Blot testing. JAMA, 1988; 260: 674-679.
14. Midthun K, Garrison L, Clements ML, Farzadegan H, Fernie B. Quin. Frequency of indeterminate Western Blot tests in healthy adults at low risk for HIV infection. J Infect Dis, 1990; 162: 1379-1382.
15. Roy S, Portnoy J, Wainberg MA. Need for caution in interpretation of Western blot tests for HIV. JAMA, 1987; 257: 1047.
16. Mortimer PP. The fallibility of HIV Western blot. Lancet, 1991; 337: 286-287.
17. Andrade VL, Avelleria JC, Marques A, Vianna FR. Leprosy as cause of false-positive results in serological assays for detection of antibodies to HIV-1. Int J Lep, 1991; 39: 125-126.
18. Branson BM. Rapid tests for HIV antibody. AIDS Rev, 2000; 2: 76-83.
19. Burke DS, Brundage JF, Redfield RR, Damato JJ, Schable CA, Putman P, Visintine R, Kim HI. Measurement of the false positive rate in a screening program for human immunodeficiency virus infections. N Engl J Med, 1988; 319: 961-964.
20. Celum CL, Coombs RW, Jones M, Murphy V, Fisher L, Grant C, Corey L, Inui T, Wener MH, Holmes KK. Risk factors for repeatedly reactive HIV-1 EIA and indeterminate Western blots: a population-based case control study. Arch Intern Med, 1994; 154: 1129-1137.
21. Celum CL, Coombs RW, Lafferty W, Inui TS, Louie PH, Gates CA, McCreedy BJ, Egan R, Grove T, Alexander S. Indeterminate human immunodeficiency virus type 1 Western blots: seroconversion risk, specificity of supplemental tests, and an algorithm for evaluation. J. Infect. Dis, 1991; 164: 656-664.
22. Couroucé A-M, Muller JY, Richard D. False-positive Western blot tests reactions to human immunodeficiency virus in blood donors. Lancet, 1986; 2: 921-922.
23. Dock NL, Kleinman SH, Rayfield MA, Schable CA, Williams AE, Dodi RY. Human immunodeficiency virus infection and indeterminate Western blot patterns. Arch Intern Med, 1991; 151: 525-530.
24. Biberfield G, Bredberg-Raden U, Bottiger B, Putkonen PO, Blomberg J, Juto P, Wadell G. Blood donor sera with false-positive western blot reactions to human immunodeficiency virus. Lancet, 1986; 2: 289-290.
25. Biggar RJ, Gigase PL, Melbye M, Kestens L, Sarin PS, Bodner AJ, Demedts P, Stevens WJ, Paluku L, Delacollette C et al. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet, 1985; 2(8454): 520-523.
26. Doran TI, Parra E. False-Positive and Indeterminate Human Immunodeficiency Virus Test Results in Pregnant Women. Arch Fam Med, 2000; 9: 924-929.
27. Ghys PD, Belec L, Diallo MO, Ettiegne-Traore V, Becquart P, Maurice C, Nkengasong JN, Coulibaly IM, Greenberg AE, Laga M, Wiktor SZ. Cervico-vaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan, Cote d'Ivoire. AIDS, 2000; 14: 2603-2608.
28. Kashala O, Marlink R, Ilunga M, Diese M, Gormus B, Xu K, Mukeba P, Kasongo K, Essex M. Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan. J Infect Dis, 1994; 169: 296-304.
29. Mason A, Xu L, Guo L, Munoz S, Jaspan JB, Bryer-Ash M, Cao Y, Sander DM, Shoenfeld Y, Ahmed A, Van de Water J, Gershwin ME, Garry RF. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet, 1998; 351(9116): 1620-1624.
30. Moore JD, Cone EJ, Alexander SS, Jr. HTLV-III seropositivity in 1971-1972 parenteral drug abusers-a case of false positives for evidence of viral exposure?. N Engl J Med, 1986; 314: 1387-1388.
31. Simonsen L, Buffington J, Shapiro CN, Holman RC, Strine TW, Grossman BJ, Williams AE, Schonberger LB. Multiple false reactions in viral antibody screening assays after influenza vaccination. Am J Epidemiol, 1995; 141: 1089-1096.
32. Volsky DJ, Wu YT, Stevenson M, Dewhurst S, Sinangil F, Merino F, Rodriguez L, Godoy G. Antibodies to HTLV-III/LAV in Venezuelan patients with acute malarial infections. N Engl J Med, 1986; 314: 647-648.
33. Faulk WP, Labarrere CA. HIV proteins in normal human placentae. Am J Rep Immunol, 1991; 25: 99-104.
34. Kion TA, Hoffman GW. Anti-HIV and anti-anti-MHC antibodies in alloimmune and auto immune mice. Science, 1991; 253: 1138-1140.
35. Strandstrom HV, Higgins JR, Mossie K, Theilen GH. Studies with canine sera that contain antibodies which recognize human immunodeficiency virus structural proteins. Cancer Res, 1990; 50(Suppl 17): 5628-5630.
36. Willman JH, Martins TB, Jaskowski TD, Hill HR, Litwin CM. Heterophile Antibodies to Bovine and Caprine Proteins Causing False-Positive Human Immunodeficiency Virus Type 1 and Other Enzyme-Linked Immunosorbent Assay Results. Clin Diag Lab Immunol, 1999; 6: 615-616.